Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 6/20 | 0.74 |
| ▸ | MEN1 | O00255 | 5/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.74 |
| ▸ | MAPT | P10636 | 4/20 | 0.74 |
| ▸ | POLB | P06746 | 3/20 | 0.74 |
| ▸ | BAZ1A | Q9NRL2 | 2/20 | 0.67 |
| ▸ | NAMPT | P43490 | 2/20 | 0.65 |
| ▸ | KDR | P35968 | 1/20 | 0.60 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | PPIF | P30405 | 1/20 | 0.52 |
| ▸ | PPIA | P62937 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | MYOC | Q99972 | 1/20 | 0.51 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.51 |
| ▸ | CDK2 | P24941 | 1/20 | 0.51 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30542216 | 0.89 | KDR (0.60) | NPC1MEN1KMT2AMAPTPOLB | |
| SCHEMBL651929 | 0.86 | NPC1 (1.00) | NPC1MEN1KMT2AMAPTPOLB | |
| SCHEMBL31054249 | 0.86 | NPC1 (1.00) | NPC1MEN1KMT2AMAPTPOLB | |
| SCHEMBL5658310 | 0.84 | NPC1 (0.88) | NPC1MEN1KMT2AMAPTPOLB | |
| SCHEMBL30503654 | 0.81 | NPC1 (0.57) | NPC1MEN1KMT2AMAPTPOLB | |
| SCHEMBL29024929 | 0.81 | NPC1 (0.57) | NPC1MEN1KMT2AMAPTPOLB | |
| SCHEMBL5655823 | 0.81 | NPC1 (0.88) | NPC1MEN1KMT2AMAPTPOLB | |
| SCHEMBL5661569 | 0.80 | NPC1 (0.81) | NPC1MEN1KMT2AMAPTPOLB | |
| SCHEMBL6302158 | 0.80 | MEN1 (0.68) | NPC1MEN1KMT2AMAPTPOLB | |
| SCHEMBL5657576 | 0.79 | NPC1 (0.78) | NPC1MEN1KMT2AMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7285563-B2 | Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain | MERCK SHARP & DOHME LTD. (GB) | 2007-10-23 | — | — | US | disclosed |
| US-20050107388-A1 | Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain | MERCK SHARP & DOHME LTD. (GB) | 2005-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107388-A1 | Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain | ARRB1, OPRL1, CNR1 | NPC1 959/4885MEN1 4770/4885KMT2A 4465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.